MedPath

Beinaglutide

Generic Name
Beinaglutide
Drug Type
Biotech
CAS Number
123475-27-4
Unique Ingredient Identifier
38I1O6L31D

Overview

Beinaglutide is under investigation in clinical trial NCT03829891 (Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus).

Background

Beinaglutide is under investigation in clinical trial NCT03829891 (Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus).

Indication

用于成人2型糖尿病患者控制血糖;适用于单用二甲双胍血糖控制不佳的患者。

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath